Community/Retail

Between 10% and 20% of students in kindergarten through high school have chronic illness.

At the ASHP Midyear 2017 meeting, Amy Westmoreland, pharmacy manager and clinical pharmacist at Carilion Giles Community Hospital discusses the importance of collaboration between hospital pharmacists and physicians.

The FDA extended the approval of evolocumab (Repatha, Amgen) to include the prophylaxis of heart attacks, strokes, and coronary revascularizations in adults with established heart disease.

Current pharmacy technician members of ASHP will be automatically incorporated into the forum.

ASHP officials took time to recognize some of their own.

The medication is indicated for the long-term, once-daily maintenance treatment of patients with chronic obstructive pulmonary disease.

Several people were honored this week at Baxter Healthcare Corporation’s Leadership Excellence Awards in Pharmacy, or LEAP, ceremony.

Drop the modifier, as it is causing a rift in the profession.

ASHP’s 2017 Midyear Clinical Meeting is set to begin, and Pharmacy Times will be on site covering it.

As professions expand their scopes of practice, it is critical to step back periodically and examine how the change has affected the profession and the individuals within the profession.

The FDA has approved trastuzumab-dkst (Ogivri, Mylan GmbH) as a biosimilar to trastuzumab (Herceptin, Genentech), the first biosimilar for the treatment of certain breast and stomach cancers.

Nearly 21 million individuals with HIV had access to antiretroviral therapy (ART) in June 2017 compared to 685,000 HIV-positive patients in 2000.

Rising cancer drug costs have become inreasingly worrisome for patients and health care providers. Despite the entry of competitors in the market, treatment costs continue to climb over time, according to a study recently published by the Journal of Clinical Oncology.

The FDA has approved Indivior’s Sublocade, the first once-monthly injectable buprenorphine product for the treatment of moderate-to-severe opioid use disorder (OUD).

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

With Midyear approaching, many are dreaming of finding that perfect program. Now is the time to start coming up with a game plan.

In a world where we are bombarded with various diets, what does the evidence say?

New Hampshire is seeking to join the list of states allowing pharmacists to provide contraception to women without a prescription.

Is there a way to maintain these services in a cost-effective way so that all stakeholders benefit?

Apple announces a study to investigate whether their Apple Watch can detect afib in patients.

The FDA has extended the approval of raltegravir (Isentress, Merck), an integrase inhibitor for use in combination with other antiretroviral agents, for the treatment of HIV-1 in newborn infants weighing at least 2 kg.

Americans are getting tested and diagnosed with HIV sooner after infection, according to a recently-published CDC Vital Signs report.

An infant’s sex-specific gut microbiome following maternal asthma during pregnancy may influence their risk of developing childhood asthma.

Currently, more women practice in pharmacy than men, and it is expected that the number of women practicing will continue to rise.

Here are tips on managing people well, ensuring fairness, and behaving like a boss who people actually respect and want to emulate.

Here are some ways to cope with any stress or challenges that community pharmacy may bring.

Currently, the plan is to role out Viagra Connect in the first or second quarter of 2018.

The FDA is monitoring reports of adverse events associated with biotin interference with laboratory tests and will update the public if significant new information becomes available.

As the most accessible health care providers, pharmacists may be asked questions regarding physical activity from patients with arthritis, and it’s important to advise them to keep moving.

It’s been more than 6 decades since Professor R. Keith Campbell, from Washington State University, was diagnosed with diabetes.